Related Experiment Videos
Multimodality approaches for pancreatic cancer.
Gary Y Yang1, Timothy D Wagner, Martin Fuss
1Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
CA: a Cancer Journal for Clinicians
|November 12, 2005
Summary
The management of advanced pancreatic cancer is changing due to new clinical trials. This review summarizes current best practices and future strategies for combined-modality therapy in pancreatic cancer patients.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Pancreatic cancer treatment is complex, involving varied approaches for locally advanced disease.
- Clinical trials are advancing the understanding of combined-modality therapy.
Purpose of the Study:
- To summarize the current state-of-the-art management for pancreatic cancer.
- To outline future directions for multimodality treatment approaches.
Main Methods:
- Review of recent major, multi-institutional clinical trials.
- Analysis of variations in staging and surgical expertise.
- Evaluation of definitive versus adjuvant chemoradiotherapy protocols.
Main Results:
- The role of combined-modality therapy is evolving.
- Clinicians face challenges in applying optimal treatment strategies.
- Standardization of care is needed for advanced pancreatic cancer.
Conclusions:
- Multimodality therapy is key for advanced pancreatic cancer.
- Further research and standardized protocols are essential.
- Integrating surgical and oncologic expertise improves outcomes.